Pharma R&D Annual Review 2024

Welcome to the Pharma R&D Annual Review

For over 30 years, the Pharma R&D Annual Review has tracked how the climate is shifting, revealing the currents and tides that shape the drug development landscape.

This year, we’ve taken the industry’s temperature by analyzing over 22,000 drugs and examining pipeline by company, therapeutic area, disease, target, drug type, region and much more.

Browse our reports, infographics, audiobook and webinar below, to help you determine where the outlook is sunny, and where storm clouds are gathering.

PDF preview of the Annual Pharma R&D 2024 White Paper.
White paper
Clinical

R&D Annual Review

The 32nd edition of our comprehensive R&D climate report. We've analyzed over 22,000 drugs in development to help you determine where the outlook is sunny, and where the storm clouds are gathering.

Preview of the Pharma R&D Audiobook.
Audiobook
Clinical

Annual Review Audiobook

Enjoy the full Pharma R&D Annual Review 2024 in audiobook format. Sit back, listen and discover how the climate is shifting, revealing the current and tides that shape the drug development landscape.

''
Infographic
Clinical

Pharma R&D Infographic

Discover the recording breaking year in numbers. From pipeline size and regional breakdown, to the largest therapeutic area and development phase.

Learn more about our suite of solutions providing the industry's most comprehensive, reliable, and up-to-date global R&D intelligence.

New Active Substances Launched During 2023

Find out which new drugs made it to market in last year

PDF preview of the NAS infographic.
Infographic
Clinical

NAS Infographic

Insights from our supplemental report on new active substances launched in 2023.

NAS Whitepaper PDF coming soon.
Report
Clinical

NAS Report

The Pharma R&D Annual Review 2024 Supplement looks at new active substances (NASs), drugs launched onto the market for the first time, during 2023

Pharma R&D Annual Review 2024 Webinar
NOW AVAILABLE ON-DEMAND

Join the Citeline team for its long-running annual review of trends in pharma R&D. In this webinar, you will learn how the pharma R&D climate is changing, where the outlook is sunny and where storm clouds are gathering.

Register to gain access to the on-demand webinar so you can forecast for success in 2024.

''

Make the insights matter

Book a demo to learn more about Biomedtracker. Book a demo to learn more about Pharmaprojects.
Book a demo today

Learn more about our suite of solutions providing the industry's leading global R&D intelligence.

Professionals submitting a form to find out more about Citeline.
Citeline may contact you about relevant products, services and content. To opt out of these communications or to manage what you receive, please visit our Preference Center.

Your information will be used in accordance with our Privacy notice.

Thank you for your interest in Citeline. Your message has been submitted and our team will be in touch soon.